Studies have shown that anti-inflammatory treatment can relieve fatigue; for example, selective 5-HT reuptake inhibitors exhibit the most beneficial effects in restraining the inflammation markers in patients with depression [39]. This evidence concerns the gene HTR5A and major depressive disorder.